SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-017447
Filing Date
2024-02-27
Accepted
2024-02-27 15:27:15
Documents
2
Period of Report
2024-02-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2721
2 POWER OF ATTORNEY ea0200812ex24_inmed.htm EX-24 8205
  Complete submission text file 0001213900-24-017447.txt   12412
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 310-815 WEST HASTINGS ST. VANCOUVER A1 V6C1B4
Business Address
Jagpal Netta (Reporting) CIK: 0002013468 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39685 | Film No.: 24685947